Skip to content
healthcare.dev

ARISTADA INITIO

NDC 65757-500, aripiprazole lauroxil, injection, suspension, extended release, from Alkermes, Inc..

Product NDC
65757-500
Status
Listed
Labeler
Alkermes, Inc.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209830
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65757-500 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE LAUROXIL675 mg/2.4mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
65757-500-03657570500031 SYRINGE in 1 CARTON (65757-500-03) / 2.4 mL in 1 SYRINGE
65757-500-04657570500041 SYRINGE in 1 CARTON (65757-500-04) / 2.4 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65757-500
  • NADAC price for package 65757050003

    GET /v1/drugs/nadac/65757050003

Use it

Look up 65757-500 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65757-500 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65757-500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.